Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Ann Vasc Surg ; 40: 57-62, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27554694

RESUMO

BACKGROUND: We set out to compare the rates of Medicare reimbursement to physicians versus hospitals for several major vascular procedures over a period of 5 years. METHODS: We queried the Wolters Kluwer MediRegs database to collect Medicare reimbursement data from fiscal years 2011 to 2015. We surveyed reimbursements for carotid endarterectomy, carotid angioplasty and stenting, femoropopliteal bypass, and lower extremity fem-pop revascularization with stenting. Based on data availability, we surveyed physician reimbursement data on the national level and in both medically overserved and underserved areas. Hospital reimbursement rates were examined on a national level and by hospitals' teaching and wage index statuses. RESULTS: We found that for all 4 vascular procedures, Medicare reimbursements to hospitals increased by a greater percentage than to physicians. By region, underserved areas had lower physician reimbursements than the national average, while the opposite was true for overserved areas. Additionally, for hospital Medicare reimbursements, location in a high wage index accounted for a significant increase in reimbursement over the national average, with teaching status contributing to this increase in a smaller extent. CONCLUSIONS: These data on Medicare reimbursements indicate that payments to hospitals are increasing more significantly than to physicians. This disparity in pay changes affects both independent and academic vascular surgeons. Medicare should consider pay increases to independent providers in accordance to the hospital pay increase.


Assuntos
Angioplastia/economia , Grupos Diagnósticos Relacionados/economia , Economia Hospitalar , Endarterectomia das Carótidas/economia , Planos de Pagamento por Serviço Prestado/economia , Medicare/economia , Médicos/economia , Enxerto Vascular/economia , Angioplastia/instrumentação , Angioplastia/tendências , Área Programática de Saúde/economia , Bases de Dados Factuais , Grupos Diagnósticos Relacionados/tendências , Economia Hospitalar/tendências , Endarterectomia das Carótidas/tendências , Planos de Pagamento por Serviço Prestado/tendências , Disparidades em Assistência à Saúde/economia , Preços Hospitalares , Custos Hospitalares , Hospitais de Ensino/economia , Humanos , Área Carente de Assistência Médica , Medicare/tendências , Médicos/tendências , Salários e Benefícios/economia , Stents/economia , Fatores de Tempo , Estados Unidos , Enxerto Vascular/tendências
2.
Ann Vasc Surg ; 35: 46-52, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27239000

RESUMO

BACKGROUND: Native arteriovenous fistulas (AVFs) have a high 1 year failure rate leading to a need for secondary procedures. We set out to create a predictive model of early failure in patients undergoing first-time AVF creation, to identify failure-associated factors and stratify initial failure risk. METHODS: The Vascular Study Group of New England (VSGNE) (2010-2014) was queried to identify patients undergoing first-time AVF creation. Patients with early (within 3 months postoperation) AVF failure (EF) or no failure (NF) were compared, failure being defined as any AVF that could not be used for dialysis. A multivariate logistic regression predictive model of EF based on perioperative clinical variables was created. Backward elimination with alpha level of 0.2 was used to create a parsimonious model. RESULTS: We identified 376 first-time AVF patients with follow-up data available in VSGNE. EF rate was 17.5%. Patients in the EF group had lower rates of hypertension (80.3% vs. 93.2%, P = 0.003) and diabetes (47.0% vs. 61.3%, P = 0.039). EF patients were also more likely to have radial artery inflow (57.6% vs. 38.4%, P = 0.011) and have forearm cephalic vein outflow (57.6% vs. 36.5%, P = 0.008). Additionally, the EF group was noted to have significantly smaller mean diameters of target artery (3.1 ± 0.9 vs. 3.6 ± 1.1, P = 0.002) and vein (3.1 ± 0.7 vs. 3.6 ± 0.9, P < 0.001). Multivariate analyses revealed that hypertension, diabetes, and vein larger than 3 mm were protective of EF (P < 0.05). The discriminating ability of this model was good (C-statistic = 0.731) and the model fits the data well (Hosmer-Lemeshow P = 0.149). ß-estimates of significant factors were used to create a point system and assign probabilities of EF. CONCLUSIONS: We developed a simple model that robustly predicts first-time AVF EF and suggests that anatomical and clinical factors directly affect early AVF outcomes. The risk score has the potential to be used in clinical settings to stratify risk and make informed follow-up plans for AVF patients.


Assuntos
Derivação Arteriovenosa Cirúrgica/efeitos adversos , Técnicas de Apoio para a Decisão , Falência Renal Crônica/terapia , Diálise Renal , Adulto , Idoso , Idoso de 80 Anos ou mais , Área Sob a Curva , Distribuição de Qui-Quadrado , Bases de Dados Factuais , Feminino , Humanos , Falência Renal Crônica/diagnóstico , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , New England , Seleção de Pacientes , Valor Preditivo dos Testes , Curva ROC , Reprodutibilidade dos Testes , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Fatores de Tempo , Falha de Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA